Navigating the complex global patent landscape.
New White Paper Available: EU Revision of the Pharmaceutical Legislation. To request access, email thoughtleadershipgroup@iqvia.com
On 26 April 2023, the European Commission proposed their long-awaited revisions to the EU’s pharmaceutical legislation aimed at making medicines more available, accessible and affordable. We analysed five of the more contentious proposals, applying IQVIA’s unique data and insights to explore their impact on life science companies, payers and, ultimately, evaluate the extent at which the Commission’s proposals may shake up European healthcare.
The five areas are:
Although this proposal will likely undergo change and not be implemented until the second half of this decade, it is important to engage in this conversation early and calculate its impact on your organisation.
These are the essential steps IQVIA recommends to ensure you are ready:
To request the full white paper with deeper analyses, or if you would like IQVIA to profile how this proposal may impact you, please reach out to your IQVIA representative or directly to thoughtleadershipgroup@iqvia.com
Navigating the complex global patent landscape.
Generics is about competition
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
Analyze industry leading sales and medical data in a standardized and comparable way, including cross-country analysis of performance and additional insights into global and regional markets.
Get an up to date view of key performance indicators globally, regionally, or locally.
Be proactive about growing your brand using the latest in data, analytics, and domain expertise.
Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.